scispace - formally typeset
C

Celia Moss

Researcher at Boston Children's Hospital

Publications -  120
Citations -  4944

Celia Moss is an academic researcher from Boston Children's Hospital. The author has contributed to research in topics: Medicine & Mutation. The author has an hindex of 33, co-authored 105 publications receiving 4477 citations. Previous affiliations of Celia Moss include Children's of Alabama.

Papers
More filters
Journal ArticleDOI

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

TL;DR: A consensus statement on the current guidelines for diagnosis and management of neurofibromatosis 1 is produced, based on published clinical studies and on the pooled knowledge of experts with experience of providing multidisciplinary clinical and molecular services for NF1 patients.
Journal ArticleDOI

A Novel X-Linked Disorder of Immune Deficiency and Hypohidrotic Ectodermal Dysplasia Is Allelic to Incontinentia Pigmenti and Due to Mutations in IKK-gamma (NEMO)

TL;DR: A new X-linked recessive immunodeficiency syndrome is defined, distinct from other types of HED and immunODeficiency syndromes, and the data provide further evidence that the development of ectodermal appendages is mediated through a tumor necrosis factor/tumor necrosis factors receptor-like signaling pathway, with the IKK signalsome complex playing a significant role.
Journal ArticleDOI

Randomised controlled study of early pulsed dye laser treatment of uncomplicated childhood haemangiomas: results of a 1-year analysis

TL;DR: PDL treatment in uncomplicated haemangiomas is no better than a wait-and-see policy, and the only objective measure of resolution that improved with PDL treatment was haemagioma redness.
Journal ArticleDOI

The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia

TL;DR: Rspo4 expression was specifically localized to developing mouse nail mesenchyme at embryonic day 15.5, suggesting a crucial role in nail morphogenesis, and homozygous or compound heterozygous mutations in the gene encoding R-spondin 4 (RSPO4) in eight affected families were identified.